• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能获得性突变型p53通过抑制AMPK激活促进细胞生长和癌细胞代谢。

Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.

作者信息

Zhou Ge, Wang Jiping, Zhao Mei, Xie Tong-Xin, Tanaka Noriaki, Sano Daisuke, Patel Ameeta A, Ward Alexandra M, Sandulache Vlad C, Jasser Samar A, Skinner Heath D, Fitzgerald Alison Lea, Osman Abdullah A, Wei Yongkun, Xia Xuefeng, Songyang Zhou, Mills Gordon B, Hung Mien-Chie, Caulin Carlos, Liang Jiyong, Myers Jeffrey N

机构信息

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Mol Cell. 2014 Jun 19;54(6):960-974. doi: 10.1016/j.molcel.2014.04.024. Epub 2014 May 22.

DOI:10.1016/j.molcel.2014.04.024
PMID:24857548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4067806/
Abstract

Many mutant p53 proteins (mutp53s) exert oncogenic gain-of-function (GOF) properties, but the mechanisms mediating these functions remain poorly defined. We show here that GOF mutp53s inhibit AMP-activated protein kinase (AMPK) signaling in head and neck cancer cells. Conversely, downregulation of GOF mutp53s enhances AMPK activation under energy stress, decreasing the activity of the anabolic factors acetyl-CoA carboxylase and ribosomal protein S6 and inhibiting aerobic glycolytic potential and invasive cell growth. Under conditions of energy stress, GOF mutp53s, but not wild-type p53, preferentially bind to the AMPKα subunit and inhibit AMPK activation. Given the importance of AMPK as an energy sensor and tumor suppressor that inhibits anabolic metabolism, our findings reveal that direct inhibition of AMPK activation is an important mechanism through which mutp53s can gain oncogenic function.

摘要

许多突变型p53蛋白(mutp53s)具有致癌性的功能获得(GOF)特性,但介导这些功能的机制仍不清楚。我们在此表明,具有GOF的mutp53s在头颈部癌细胞中抑制AMP激活的蛋白激酶(AMPK)信号传导。相反,在能量应激下,下调具有GOF的mutp53s可增强AMPK激活,降低合成代谢因子乙酰辅酶A羧化酶和核糖体蛋白S6的活性,并抑制有氧糖酵解潜能和侵袭性细胞生长。在能量应激条件下,具有GOF的mutp53s而非野生型p53优先结合AMPKα亚基并抑制AMPK激活。鉴于AMPK作为能量传感器和抑制合成代谢的肿瘤抑制因子的重要性,我们的研究结果表明,直接抑制AMPK激活是mutp53s获得致癌功能的重要机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/cad5c6d2f2e1/nihms590697f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/7f8917a6b4aa/nihms590697f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/f97ddbaf1ff2/nihms590697f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/ba2d865f1df3/nihms590697f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/8c708ab84ad5/nihms590697f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/a8a491bc49c9/nihms590697f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/cd9cd9e8613d/nihms590697f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/cad5c6d2f2e1/nihms590697f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/7f8917a6b4aa/nihms590697f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/f97ddbaf1ff2/nihms590697f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/ba2d865f1df3/nihms590697f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/8c708ab84ad5/nihms590697f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/a8a491bc49c9/nihms590697f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/cd9cd9e8613d/nihms590697f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32b7/4067806/cad5c6d2f2e1/nihms590697f7.jpg

相似文献

1
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.功能获得性突变型p53通过抑制AMPK激活促进细胞生长和癌细胞代谢。
Mol Cell. 2014 Jun 19;54(6):960-974. doi: 10.1016/j.molcel.2014.04.024. Epub 2014 May 22.
2
Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.功能获得性突变 p53 通过靶向转录因子 FOXO3a 和 FOXM1 促进头颈部鳞状细胞癌细胞的致癌潜能。
Oncogene. 2018 Mar;37(10):1279-1292. doi: 10.1038/s41388-017-0032-z. Epub 2017 Dec 22.
3
Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.乙酰辅酶A羧化酶重塑癌症代谢,使癌细胞能够在西妥昔单抗抑制瓦伯格效应的情况下存活。
Cancer Lett. 2017 Jan 1;384:39-49. doi: 10.1016/j.canlet.2016.09.020. Epub 2016 Sep 28.
4
AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab.AMPK介导的能量稳态及其对癌细胞对西妥昔单抗反应和耐药性的相关代谢影响。
Oncotarget. 2015 May 10;6(13):11507-18. doi: 10.18632/oncotarget.3432.
5
Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.AMP 激活的蛋白激酶的激活参与长春新碱诱导的 B16 黑色素瘤细胞凋亡。
J Cell Physiol. 2011 Jul;226(7):1915-25. doi: 10.1002/jcp.22522.
6
p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.p53 靶向 lincRNA-p21 通过抑制头颈部鳞状细胞癌中的 JAK2/STAT3 信号通路发挥肿瘤抑制作用。
Mol Cancer. 2019 Mar 11;18(1):38. doi: 10.1186/s12943-019-0993-3.
7
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.和厚朴酚通过 LKB1 依赖途径激活乳腺癌细胞中的 AMP 激活的蛋白激酶并抑制乳腺癌发生。
Breast Cancer Res. 2012 Feb 21;14(1):R35. doi: 10.1186/bcr3128.
8
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.琥珀酸脱氢酶缺乏型肾细胞癌中的糖酵解转换会降低 AMPK 水平,增加合成代谢倾向,并降低细胞内铁水平。
Cancer Cell. 2011 Sep 13;20(3):315-27. doi: 10.1016/j.ccr.2011.07.018.
9
Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.小檗碱和二甲双胍对胰腺癌细胞中mTORC1、ERK、DNA合成及增殖的抑制作用:剂量依赖性的AMPK依赖和非依赖机制
PLoS One. 2014 Dec 10;9(12):e114573. doi: 10.1371/journal.pone.0114573. eCollection 2014.
10
Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells.激活 AMP 激活的蛋白激酶(AMPK)介导了白花丹醌诱导的培养的人结肠癌细胞凋亡和生长抑制。
Cell Signal. 2013 Oct;25(10):1993-2002. doi: 10.1016/j.cellsig.2013.05.026. Epub 2013 May 25.

引用本文的文献

1
Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells.热休克蛋白70(HSP70)抑制剂与阿霉素对功能获得性突变型p53乳腺癌细胞的协同抗癌活性
Biomedicines. 2025 Apr 24;13(5):1034. doi: 10.3390/biomedicines13051034.
2
The Role of the Extracellular Matrix in Cancer Prevention.细胞外基质在癌症预防中的作用。
Cancers (Basel). 2025 Apr 29;17(9):1491. doi: 10.3390/cancers17091491.
3
The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations.p53突变在对有丝分裂异常的早期和晚期反应中的作用。

本文引用的文献

1
AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.AMP 激活的蛋白激酶通过磷酸化 MDMX 并抑制其活性诱导 p53。
Mol Cell Biol. 2014 Jan;34(2):148-57. doi: 10.1128/MCB.00670-13. Epub 2013 Nov 4.
2
Metabolic regulation by p53 family members.p53 家族成员的代谢调控。
Cell Metab. 2013 Nov 5;18(5):617-33. doi: 10.1016/j.cmet.2013.06.019. Epub 2013 Aug 15.
3
AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo.AMPK 是瓦博格效应的负调节剂,能在体内抑制肿瘤生长。
Biomolecules. 2025 Feb 8;15(2):244. doi: 10.3390/biom15020244.
4
Metabolic regulation by p53: Implications for cancer therapy.p53介导的代谢调控:对癌症治疗的启示
Mol Cells. 2025 Apr;48(4):100198. doi: 10.1016/j.mocell.2025.100198. Epub 2025 Feb 20.
5
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.从血液系统恶性肿瘤中p53的调控到去调控:对诊断、预后和治疗的影响
Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9.
6
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.靶向突变型 p53:乳腺癌发病机制及其他方面的关键因素。
Cell Commun Signal. 2024 Oct 10;22(1):484. doi: 10.1186/s12964-024-01863-9.
7
Mitochondrial inhibitors: a new horizon in breast cancer therapy.线粒体抑制剂:乳腺癌治疗的新视野。
Front Pharmacol. 2024 Jul 4;15:1421905. doi: 10.3389/fphar.2024.1421905. eCollection 2024.
8
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions.近期关于突变型 p53 的研究进展:揭示新的致癌作用、降解途径和治疗干预措施。
Biomolecules. 2024 May 31;14(6):649. doi: 10.3390/biom14060649.
9
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
10
Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.Li Fraumeni 综合征成人接受每年 MRI 监测的二甲双胍癌症精准预防试验(MILI):一项随机对照试验方案。
Trials. 2024 Feb 3;25(1):103. doi: 10.1186/s13063-024-07929-w.
Cell Metab. 2013 Jan 8;17(1):113-24. doi: 10.1016/j.cmet.2012.12.001. Epub 2012 Dec 27.
4
p53 mutations in cancer.癌症中的 p53 突变。
Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
5
TAp63 is a master transcriptional regulator of lipid and glucose metabolism.TAp63 是脂质和葡萄糖代谢的主要转录调控因子。
Cell Metab. 2012 Oct 3;16(4):511-25. doi: 10.1016/j.cmet.2012.09.006.
6
Regulation of lipid metabolism by p53 - fighting two villains with one sword.p53 通过调节脂质代谢来发挥作用——一石二鸟。
Trends Endocrinol Metab. 2012 Nov;23(11):567-75. doi: 10.1016/j.tem.2012.06.007. Epub 2012 Jul 20.
7
AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells.AMPK 通过磷酸化和失活 SIRT1 促进肝癌细胞中的 p53 乙酰化。
Cancer Res. 2012 Sep 1;72(17):4394-404. doi: 10.1158/0008-5472.CAN-12-0429. Epub 2012 Jun 22.
8
Mutant p53: one name, many proteins.突变型 p53:一个名字,多种蛋白。
Genes Dev. 2012 Jun 15;26(12):1268-86. doi: 10.1101/gad.190678.112.
9
Metabolic reprogramming: a cancer hallmark even warburg did not anticipate.代谢重编程:癌症的一个标志,甚至连沃伯格都没有预料到。
Cancer Cell. 2012 Mar 20;21(3):297-308. doi: 10.1016/j.ccr.2012.02.014.
10
AMPK: a nutrient and energy sensor that maintains energy homeostasis.AMPK:一种营养和能量传感器,可维持能量平衡。
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62. doi: 10.1038/nrm3311.